Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 92,714 | 74,800 | 74,100 | 55,586 | 81,214 |
| Cost of Goods | 12,213 | 6,800 | 8,000 | 8,386 | 7,142 |
| Gross Profit | 80,501 | 68,000 | 66,100 | 47,200 | 74,072 |
| Operating Expenses | 74,023 | 64,700 | 69,200 | 63,898 | 73,146 |
| Operating Income | 6,691 | 4,100 | -3,100 | -16,312 | 1,068 |
| Other Income | 41 | -2,600 | 3,000 | -312 | -3,113 |
| Pre-tax Income | 6,732 | 1,500 | -100 | -16,624 | -2,045 |
| Income Tax | 3,925 | 2,500 | 1,100 | -4,176 | 1,059 |
| Net Income Continuous | 2,807 | -1,000 | -1,200 | -12,448 | -3,104 |
| Net Income | $2,907 | $-1,100 | $-1,200 | $-12,448 | $-3,104 |
| EPS Basic Total Ops | 0.05 | -0.02 | -0.02 | -0.19 | N/A |
| EPS Basic Continuous Ops | 0.05 | -0.02 | -0.02 | -0.19 | 0.00 |
| EPS Diluted Total Ops | 0.05 | -0.02 | -0.02 | -0.19 | N/A |
| EPS Diluted Continuous Ops | 0.08 | -0.02 | -0.02 | -0.19 | 0.01 |
| EPS Diluted Before Non-Recurring Items | 0.05 | -0.02 | -0.01 | N/A | N/A |
| EBITDA(a) | $14,390 | $6,843 | $-3,393 | $-10,391 | $8,623 |